288
Views
10
CrossRef citations to date
0
Altmetric
Lens

Posterior Capsule Rupture during Cataract Surgery in Eyes Receiving Intravitreal anti-VEGF Injections

ORCID Icon, ORCID Icon, , , , & show all
Pages 179-184 | Received 07 May 2020, Accepted 07 Jul 2020, Published online: 23 Jul 2020

References

  • Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419–31. doi:10.1056/NEJMoa054481.
  • Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193–203.
  • Sun JK, Glassman AR, Beaulieu WT, Stockdale CR, Bressler NM, Flaxel C, Gross JG, Shami M, Jampol LM. Rationale and application of the protocol s anti-vascular endothelial growth factor algorithm for proliferative diabetic retinopathy. Ophthalmology. 2019;126(1):87–95. doi:10.1016/j.ophtha.2018.08.001.
  • Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: A review of literature. Eye (Lond). 2013;27(7):787–94. doi:10.1038/eye.2013.107.
  • Kim J, Ryu SY, Hong JH, Chung EJ. Incidence and risk factors for retinal detachment after cataract surgery in korea: A nationwide population-based study from 2011 to 2015. Graefes Arch Clin Exp Ophthalmol. 2019;257(10):2193–202. doi:10.1007/s00417-019-04423-x.
  • Petousis V, Sallam AA, Haynes RJ, Patel CK, Tyagi AK, Kirkpatrick JN, Johnston RL. Risk factors for retinal detachment following cataract surgery: the impact of posterior capsular rupture. Br J Ophthalmol. 2016;100(11):1461–65. doi:10.1136/bjophthalmol-2015-307729.
  • Haripriya A, Chang DF, Ravindran RD. Endophthalmitis reduction with intracameral moxifloxacin in eyes with and without surgical complications: results from 2 million consecutive cataract surgeries. J Cataract Refract Surg. 2019;45(9):1226–33. doi:10.1016/j.jcrs.2019.04.018.
  • Sparrow JM, Taylor H, Qureshi K, Smith R, Birnie K, Johnston RL. The cataract national dataset electronic multi-centre audit of 55 567 operations: risk indicators for monocular visual acuity outcomes. Eye. 2012;26:821. doi:10.1038/eye.2012.51.
  • Hahn P, Jiramongkolchai K, Stinnett S, Daluvoy M, Kim T. Rate of intraoperative complications during cataract surgery following intravitreal injections. Eye (Lond). 2016;30(8):1101–09. doi:10.1038/eye.2016.109.
  • Lee AY, Day AC, Egan C, Bailey C, Johnston RL, Tsaloumas MD, Denniston AK, Tufail A. Previous intravitreal therapy is associated with increased risk of posterior capsule rupture during cataract surgery. Ophthalmology. 2016;123(6):1252–56. doi:10.1016/j.ophtha.2016.02.014.
  • Shalchi Z, Okada M, Whiting C, Hamilton R. Risk of posterior capsule rupture during cataract surgery in eyes with previous intravitreal injections. Am J Ophthalmol. 2017;177:77–80. doi:10.1016/j.ajo.2017.02.006.
  • Nagar AM, Luis J, Kainth N, Panos GD, Mckechnie CJ, Patra S. Risk of posterior capsular rupture during phacoemulsification cataract surgery in eyes with previous intravitreal antivascular endothelial growth factor injections. J Cataract Refract Surg. 2020;46:204–08.
  • Hahn P, Yashkin AP, Sloan FA. Effect of prior anti-VEGF injections on the risk of retained lens fragments and endophthalmitis after cataract surgery in the elderly. Ophthalmology. 2016;123(2):309–15. doi:10.1016/j.ophtha.2015.06.040.
  • Narendran N, Jaycock P, Johnston RL, Taylor H, Adams M, Tole DM, Asaria RH, Galloway P, Sparrow JM. The cataract national dataset electronic multicentre audit of 55,567 operations: risk stratification for posterior capsule rupture and vitreous loss. Eye (Lond). 2009;23(1):31–37. doi:10.1038/sj.eye.6703049.
  • Jun JH, Sohn WJ, Lee Y, Kim JY. Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells. Clin Ophthalmol. 2016;10:1167–74. doi:10.2147/OPTH.S103443.
  • Danysh BP, Duncan MK. The lens capsule. Exp Eye Res. 2009;88(2):151–64. doi:10.1016/j.exer.2008.08.002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.